Nothing Special   »   [go: up one dir, main page]

ECSP066382A - Proceso de purificación - Google Patents

Proceso de purificación

Info

Publication number
ECSP066382A
ECSP066382A EC2006006382A ECSP066382A ECSP066382A EC SP066382 A ECSP066382 A EC SP066382A EC 2006006382 A EC2006006382 A EC 2006006382A EC SP066382 A ECSP066382 A EC SP066382A EC SP066382 A ECSP066382 A EC SP066382A
Authority
EC
Ecuador
Prior art keywords
purification process
terbinafine
addition salt
free base
distillation
Prior art date
Application number
EC2006006382A
Other languages
English (en)
Inventor
Ulrich Beutler
Gerhard Penn
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28686596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP066382(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP066382A publication Critical patent/ECSP066382A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82—Purification; Separation; Stabilisation; Use of additives
    • C07C209/84—Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/30—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Proceso de purificación para la preparación de la alilamina farmacéutica terbinafina de fórmula (I) en forma de base libre o en forma de sal de adición de ácido, mediante destilación de la terbinafina cruda en forma de base, preferiblemente por destilación de trayectoria corta, por ejemplo a una temperatura por encima de 100º C y presión reducida, por ejemplo a 0,2 mbar, y recuperación del producto purificado en forma de base libre o en forma de sal de adición.
EC2006006382A 2003-08-29 2006-02-17 Proceso de purificación ECSP066382A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0320312.2A GB0320312D0 (en) 2003-08-29 2003-08-29 Purification process

Publications (1)

Publication Number Publication Date
ECSP066382A true ECSP066382A (es) 2006-09-18

Family

ID=28686596

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006382A ECSP066382A (es) 2003-08-29 2006-02-17 Proceso de purificación

Country Status (25)

Country Link
US (2) US20060076227A1 (es)
EP (1) EP1694631A2 (es)
JP (1) JP5208416B2 (es)
KR (2) KR20120054109A (es)
CN (1) CN100491334C (es)
AR (1) AR045506A1 (es)
AU (1) AU2004268051B2 (es)
BR (1) BRPI0413896A (es)
CA (1) CA2536498C (es)
EC (1) ECSP066382A (es)
GB (1) GB0320312D0 (es)
IL (1) IL173709A (es)
IS (1) IS8369A (es)
MA (1) MA28030A1 (es)
MX (1) MXPA06002348A (es)
MY (1) MY149357A (es)
NO (1) NO20061404L (es)
NZ (1) NZ545445A (es)
PE (1) PE20050873A1 (es)
RU (1) RU2367649C2 (es)
SG (1) SG145782A1 (es)
TN (1) TNSN06066A1 (es)
TW (1) TWI350829B (es)
WO (1) WO2005021483A2 (es)
ZA (1) ZA200601264B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0503942D0 (en) * 2005-02-25 2005-04-06 Novartis Ag Purification process
EP1900378A1 (en) * 2006-08-31 2008-03-19 Novartis AG Pharmaceutical compositions for the treatment of fungal infections
WO2010027468A1 (en) 2008-09-05 2010-03-11 Travanti Pharma Inc. Iontophoretic drug delivery packaging

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000896B1 (en) * 1977-08-19 1982-10-13 Sandoz Ag Propenyl amines, processes for their production and pharmaceutical compositions containing them
DE19375084I2 (de) * 1979-08-22 2000-11-16 Novartis Ag Propenylamine Verfahren zu ihrer Herstellung sie enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung als Arzneimittel
US5132459A (en) * 1979-08-22 1992-07-21 Sandoz Ltd. Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
CH678527A5 (en) 1989-06-22 1991-09-30 Sandoz Ag Trans(E)-N-(1-naphthyl:methyl)-heptenyl-amine prepn. - by simultaneously converting crude mixt. contg. cis and trans isomers to salt and precipitating trans isomer
JP3116364B2 (ja) 1989-10-02 2000-12-11 萬有製薬株式会社 エンイン誘導体の製造法
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
ES2203190T3 (es) 1999-10-22 2004-04-01 Richter Gedeon Vegyeszeti Gyar R.T. Procedimiento para la preparacion de (e)-n-metil-n-(1-naftil-metil)-6,6-dimetil-hept-2-en-4-inil-1-amina.
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
ITMI20010421A1 (it) * 2001-03-01 2002-09-02 Ausimont Spa Membrane porose semipermeabili di fluoropolimeri semicristallini
ITMI20010430A1 (it) * 2001-03-02 2002-09-02 Dinamite Dipharma S P A In For Metodo per la sintesi di terbinafina
KR100459275B1 (ko) * 2001-12-28 2004-12-03 주식회사유한양행 터비나핀 또는 그의 염산염의 제조방법
ITMI20022534A1 (it) * 2002-11-29 2004-05-30 Dinamite Dipharma S P A Procedimento per la preparazione di terbinafina mediante l'uso di platino come catalizzatore.
US20060004230A1 (en) * 2004-06-30 2006-01-05 Joseph Kaspi Process for the preparation of terbinafine and salts thereof

Also Published As

Publication number Publication date
US7985323B2 (en) 2011-07-26
IS8369A (is) 2006-03-23
RU2006109640A (ru) 2007-10-10
JP2007504110A (ja) 2007-03-01
KR101233024B1 (ko) 2013-02-13
CN100491334C (zh) 2009-05-27
MXPA06002348A (es) 2006-05-22
IL173709A (en) 2012-02-29
CA2536498C (en) 2012-10-09
WO2005021483A2 (en) 2005-03-10
TNSN06066A1 (en) 2007-10-03
GB0320312D0 (en) 2003-10-01
US20090216047A1 (en) 2009-08-27
EP1694631A2 (en) 2006-08-30
WO2005021483A3 (en) 2005-05-12
BRPI0413896A (pt) 2006-10-24
KR20120054109A (ko) 2012-05-29
JP5208416B2 (ja) 2013-06-12
TW200523231A (en) 2005-07-16
NZ545445A (en) 2010-03-26
NO20061404L (no) 2006-08-25
AU2004268051B2 (en) 2009-03-05
RU2367649C2 (ru) 2009-09-20
KR20060119892A (ko) 2006-11-24
MA28030A1 (fr) 2006-07-03
PE20050873A1 (es) 2005-11-21
MY149357A (en) 2013-08-30
SG145782A1 (en) 2008-09-29
CN1845895A (zh) 2006-10-11
ZA200601264B (en) 2007-06-27
AR045506A1 (es) 2005-11-02
AU2004268051A1 (en) 2005-03-10
IL173709A0 (en) 2006-07-05
CA2536498A1 (en) 2005-03-10
TWI350829B (en) 2011-10-21
US20060076227A1 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
BRPI0410685B8 (pt) processos de purificação do 1,3-propanodiol e composição
MXPA05010682A (es) Compuestos novedosos.
MXPA03011972A (es) Arilaminas para tratamiento de condiciones asociadas con gsk-3.
CR8975A (es) Proceso para la produccion de derivados de amina opticamente activos
RS115004A (en) Novel thiophenylglycoside derivatives,methods for production thereof, medicaments comprising said compounds and use thereof
MXPA05008368A (es) 1,2,4-triazinas inhibidoras del virus de inmunodeficiencia humana.
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
JO2493B1 (en) New phenyl azatidinone with improved physical properties and methods of preparation of drugs containing it and its uses
MX2007010403A (es) Proceso de purificacion.
EA200600760A1 (ru) Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их
ECSP066382A (es) Proceso de purificación
ATE424195T1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
EA200900268A1 (ru) ЭНАНТИОМЕРНОЧИСТЫЕ β-АГОНИСТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ
WO2006099940A8 (de) Substituierte, bizyklische 8-pyrrolidino-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
MA27649A1 (fr) Derives d'acylphenyluree substitues par carbonylamino, methode de production et d'utilisation de ceux-ci.
EA200401082A1 (ru) Новые соединения бензоиндолина, способ их получения и фармацевтические композиции, которые их содержат
ITTO20030474A1 (it) Procedimento per la preparazione di dexloxiglumide
MXPA04002400A (es) Sales de acidos salicilicos, metodos para su preparacion y su uso como medicamentos.
MXPA06000995A (es) Amidas novedosas de acido indolil-3-glioxilico sustituidas en el atomo de n, uso de las mismas como medicamento y metodo para la produccion de las mismas.
BR0313228A (pt) Derivados de poliisoprenila - benzofenona, processo para sua preparação, e emprego dos mesmos
BR0312337A (pt) Derivados de ácido polienocarboxìlico, processo para a sua preparação e seu emprego
ATE345124T1 (de) Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia
TH73056A (th) กรรมวิธีการทำให้บริสุทธิ์
TH122547A (th) สารประกอบอะซาไบไซโคล[3.2.0]เฮปท์-3-อิลชนิดใหม่, กรรมวิธีสำหรับการเตรียมสิ่งเหล่านี้และองค์ประกอบทางเภสัชกรรมที่มีสิ่งเหล่านี้
TH96561A (th) แอริลซัลโฟนาไมด์ที่ถูกแทนที่